Loading...
XKRX
003060
Market cap78mUSD
Dec 05, Last price  
588.00KRW
1D
0.86%
1Q
-5.62%
Jan 2017
-97.05%
Name

Aprogen Biologics Inc

Chart & Performance

D1W1MN
XKRX:003060 chart
P/E
—
P/S
1.72
EPS
—
Div Yield, %
—
Shrs. gr., 5y
-7.43%
Rev. gr., 5y
5.77%
Revenues
67.38b
-22.88%
17,117,086,00021,137,045,00062,227,816,00016,689,083,00050,122,955,34033,769,678,25029,543,262,23033,092,222,03040,324,275,48044,122,492,68046,100,951,70045,395,389,40050,903,820,55053,319,976,20056,481,701,59065,190,359,33087,363,627,71267,378,141,000
Net income
-104.98b
L-11.24%
-10,496,595,000-5,489,801,000-8,097,501,000-704,422,000-4,560,115,000-24,870,962,000-20,852,021,000-3,887,364,7402,760,674,900-3,917,714,760-16,364,749,000-1,215,412,540-3,466,524,12018,917,569,9608,102,570,3705,583,620,100-118,269,720,510-104,978,892,000
CFO
-31.00b
L-7.89%
-4,773,709,000-3,461,909,000-4,994,895,000247,922,000-3,895,277,730-1,649,487,870-1,701,829,640-6,917,181,5701,847,053,050449,980,360-8,927,787,2801,331,380,770713,734,0208,088,157,750-6,226,540,19025,728,188,300-33,650,775,380-30,996,493,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Aprogen pharmaceuticals,Inc. manufactures and sells pharmaceutical products primarily in South Korea. It offers approximately 200 types of medicines, including ethical and over the counter drugs. The company offers its drugs for transfusion, digestive system, osteoarthritis, skeletal muscle relaxants, NSAIDs, osteoporosis, circulatory system, endocrine, respiratory system, urinary system, depilatory, antihistamines and antiallergics, obesity, brain function, neurologics, and male pattern hair loss. It also provides anti-biotic, anti-fungal, anti-viral, anti-ulcerant, anti-epliepsy products; external agents; anti-cancer drugs; amino-acid nutrient transfusion agents; and cosmetics. The company was formerly known as Schnell Biopharmaceuticals, Inc. and changed its name to Aprogen pharmaceuticals,Inc. in April 2017. Aprogen pharmaceuticals,Inc. was founded in 1960 and is headquartered in Seongnam, South Korea.
URL
http://www.aprogen-pharm.com/
IPO date
Oct 19, 1984
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT